In vivo CRO Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026

1. Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2. Executive Summary

• 2.1 Report Guide
• 2.2 Methodology
• 2.3 Market Segmentation
• 2.4 In vivo CRO Market- Key Findings, 2020

3. Strategic Imperatives on Global In vivo CRO Market

• 3.1 COVID-19 Impact Analysis
• 3.2 Market Trends- Across Types, Applications, End User Types, Countries
• 3.3 Insights into Main Market Categories
• 3.4 Market Drivers and Restraints
• 3.5 Growth Opportunities Critical for Future Success
• 3.6 Key In vivo CRO Companies

4. Global In vivo CRO Market Value Outlook to 2026 Outlook by Services

• 4.1 Rodent Based In Vivo GLP Type
  • 4.1.1 Rats Based In Vivo CRO
  • 4.1.2 Mice Based In Vivo CRO
  • 4.1.3 Others
• 4.2 Non-Rodent Based In Vivo GLP Type
  • 4.2.1 Hamsters Based In Vivo CRO
  • 4.2.2 Guinea Pigs Based In Vivo CRO
  • 4.2.3 Gerbils Based In Vivo CRO
  • 4.2.4 Others Based In Vivo CRO

5. Global In vivo CRO Market Value Outlook to 2026 Outlook by Type

• 5.1 Non GLP
  • 5.1.1 In House
  • 5.1.2 Outsourcing
• 5.2 GLP Toxicology
  • 5.2.1 In House
  • 5.2.2 Outsourcing

6. Global In vivo CRO Market Value Outlook to 2026 Outlook by Indication

• 6.1 Autoimmune/ Inflammatory Conditions
  • 6.1.1 Rheumatoid Arthritis
  • 6.1.2 Multiple Sclerosis
  • 6.1.3 Osteoarthritis
  • 6.1.4 Irritable Bowel Syndrome
  • 6.1.5 Others
• 6.2 Pain Management
  • 6.2.1 Chronic Pain
  • 6.2.2 Acute Pain
• 6.3 Oncology
  • 6.3.1 Blood Cancer
  • 6.3.2 Solid Tumor
    • 6.3.2.1 Syngeneic Model
    • 6.3.2.2 Patient Derived Xenograft
    • 6.3.2.3 Xenograft
  • 6.3.3 Others
• 6.4 CNS Conditions
  • 6.4.1 Epilepsy
  • 6.4.2 Parkinson’s Disease
  • 6.4.3 Huntington’s Disease
  • 6.4.4 Stroke
  • 6.4.5 Traumatic Brain Injury
  • 6.4.6 ALS
  • 6.4.7 Muscle Regeneration
  • 6.4.8 Others
• 6.5 Diabetes
• 6.6 Obesity
• 6.7 Others

7 Asia Pacific In vivo CRO Market Value Outlook to 2026

• 7.1 Leading In vivo CRO Types contributing to Asia Pacific market
• 7.2 Top Applications contributing to Asia Pacific In vivo CRO
• 7.3 Top countries contributing to Asia Pacific In vivo CRO

8 Europe In vivo CRO Market Value Outlook to 2026

• 8.1 Leading In vivo CRO Types contributing to Europe market
• 8.2 Top Applications contributing to Europe In vivo CRO
• 8.3 Top countries contributing to Europe In vivo CRO

9 North America In vivo CRO Market Value Outlook to 2026

• 9.1 Leading In vivo CRO Types contributing to North America market
• 9.2 Top Applications contributing to North America In vivo CRO
• 9.3 Top countries contributing to North America In vivo CRO

10 South and Central America In vivo CRO Market Value Outlook to 2026

• 10.1 Leading In vivo CRO Types contributing to South and Central America market
• 10.2 Top Applications contributing to South and Central America In vivo CRO
• 10.3 Top countries contributing to South and Central America In vivo CRO

11 Middle East Africa In vivo CRO Market Value Outlook to 2026

• 11.1 Leading In vivo CRO Types contributing to Middle East Africa market
• 11.2 Top Applications contributing to Middle East Africa In vivo CRO
• 11.3 Top countries contributing to Middle East Africa In vivo CRO

12 Business Profiles of Leading Companies

• 12.1 Business Description, SWOT and Financial Analysis of Companies in In vivo CRO market
• 12.2 American Preclinical Services
• 12.3 Charles River Laboratories
• 12.4 Covance Inc.
• 12.5 Evotec (US) Inc.
• 12.6 Icon PLC
• 12.7 Inventiv Health
• 12.8 Parexel International
• 12.9 Pharmaceutical Product Development
• 12.10 Quintiles
• 12.11 Theorem Clinical Research

13 Recent Industry Developments

14 Appendix

• 14.1 OGAnalysis Expertise
• 14.2 Sources and Methodology